Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMNVQ29)

• Drug Name: PMID23414845C30 Drug Info
• Synonyms: 4i4f; GTPL7864; BDBM50430287; 1BR

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Cross-matching ID:
  PubChem CID: 70698427
  TTD Drug ID: DMNVQ29

Molecule-Related Drug Atlas

Drug(s) Targeting Focal adhesion kinase 1 (FAK)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
VS-6063	DMGBLI3	Mesothelioma	2C51.2	Phase 2	[3]
BI-853520	DMNOSYW	Solid tumour/cancer	2A00-2F9Z	Phase 1	[4]
PF-562271	DMSLE03	Solid tumour/cancer	2A00-2F9Z	Phase 1	[5]
VS-4718	DMN9JCD	Solid tumour/cancer	2A00-2F9Z	Phase 1	[6]
GSK-2256098	DMR24MI	Pulmonary arterial hypertension	BB01.0	Phase 1	[7]
CEP-37440	DMV632P	Solid tumour/cancer	2A00-2F9Z	Phase 1	[4]
IN10018	DMPXOVA	Metastatic melanoma	2E2Z	Phase 1	[8]
1,2,4-triazolo[1,5a]pyridine derivative 1	DMIUPSA	N. A.	N. A.	Patented	[9]
BMS-536924	DMXJB4N	Discovery agent	N.A.	Investigative	[10]
PF-228	DM32FKD	Discovery agent	N.A.	Investigative	[11]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Focal adhesion kinase 1 (FAK)	TTON5IT	FAK1_HUMAN	Inhibitor	[2]

References

• [1] Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res. 2006 Aug 15;12(16):4916-24.
• [2] Structure-based discovery of cellular-active allosteric inhibitors of FAK. Bioorg Med Chem Lett. 2013 Mar 15;23(6):1779-85.
• [3] Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. J Natl Cancer Inst. 2013 Oct 2;105(19):1485-95.
• [4] Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
• [5] Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment. Mol Cancer Ther. 2011 Nov;10(11):2135-45.
• [6] FAK Inhibition disrupts a beta5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth. Mol Cancer Ther. 2014 Aug;13(8):2050-61.
• [7] A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells. Cell Cycle. 2014;13(19):3143-9.
• [8] Clinical pipeline report, company report or official report of InxMed.
• [9] Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1.Expert Opin Ther Pat. 2017 Feb;27(2):127-143.
• [10] Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitum... J Med Chem. 2005 Sep 8;48(18):5639-43.
• [11] Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem. 2007 May 18;282(20):14845-52.